Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Average Sales Price Final Rule Includes PhRMA's Estimation Method

This article was originally published in The Pink Sheet Daily

Executive Summary

Calculations of ASP for Medicare Part B drugs will be based on a rolling average percentage of price concessions divided by total sales, as proposed in manufacturers' comments. The final rule will be published Sept. 16.

You may also be interested in...



Medicare, Medicaid Rx Price Reporting Are IG Review Priorities For 2005

The HHS Inspector General will conduct several reviews related to drug manufacturers' price reporting for Medicare and Medicaid, IG's fiscal 2005 work plan says

Medicare, Medicaid Rx Price Reporting Are IG Review Priorities For 2005

The HHS Inspector General will conduct several reviews related to drug manufacturers' price reporting for Medicare and Medicaid, IG's fiscal 2005 work plan says

Average Sales Price Formula Could Produce Negative ASP, PhRMA Says

PhRMA recommends an alternative methodology that would "smooth out extreme fluctuations in ASP." The trade association proposes calculating the average ratio between rebates and sales revenue.

Topics

UsernamePublicRestriction

Register

MT101489

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel